Boehringer Ingelheim’s Spevigo approved in US to treat GPP flares in adults
Spesolimab, a monoclonal antibody that inhibits the activation of interleukin-36 (IL-36) signalling, is said to be the first…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Sep 22
Spesolimab, a monoclonal antibody that inhibits the activation of interleukin-36 (IL-36) signalling, is said to be the first…
01 Sep 22
Pfizer and BioNTech’s bivalent Covid-19 vaccine is authorised as single booster dose for adults and adolescents aged 12…
29 Aug 22
If approved, both Omicron BA.1-adapted and Omicron BA.4/BA.5-adapted bivalent vaccines will be commercially available in the European Union…
25 Aug 22
Imbruvica is a once-daily oral medication, jointly developed by Janssen and AbbVie’s subsidiary Pharmacyclics, that works by blocking…
18 Aug 22
Zynteglo offers potentially therapeutic benefit across ages and genotypes through durable transfusion independence and normal or near normal…
12 Aug 22
Vyvgart is the first neonatal Fc receptor (FcRn) blocker approved in Europe to treat generalised myasthenia gravis (gMG)…
11 Aug 22
ABX1100 is an investigational Centyrin-small interfering ribonucleic acid (siRNA) conjugate and acts on the glycogen synthase 1 (Gys1)…
10 Aug 22
The vaccine was previously approved for subcutaneous administration in the US, in September 2019, and the current EUA…
08 Aug 22
The FDA approval is based on data from the Phase 3 SPIRIT program, which showed that Myfembree reduced…
04 Aug 22
Juvéderm Volux XC is said to be the first and only hyaluronic acid (HA) filler to receive US…